J. B. Chemicals & Pharmaceuticals Limited

NSE:JBCHEPHARM.NS

Location

Market Cap

USD 2.97 B

Share Price

USD 19.00

Avg Daily Volume

216,961

Change (1 day)

-0.26%

Change (1 year)

-11.09%

Change (YTD)

-11.83%

J. B. Chemicals & Pharmaceuticals Limited EBIT Margin for the year ending March 31, 2025: 21.97%

J. B. Chemicals & Pharmaceuticals Limited EBIT Margin is 21.97% for the year ending March 31, 2025, a -4.74% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • J. B. Chemicals & Pharmaceuticals Limited EBIT Margin for the year ending March 31, 2024 was 23.06%, a 23.12% change year over year.
  • J. B. Chemicals & Pharmaceuticals Limited EBIT Margin for the year ending March 31, 2023 was 18.73%, a -10.76% change year over year.
  • J. B. Chemicals & Pharmaceuticals Limited EBIT Margin for the year ending March 31, 2022 was 20.99%, a -30.24% change year over year.
  • J. B. Chemicals & Pharmaceuticals Limited EBIT Margin for the year ending March 31, 2021 was 30.09%, a 48.97% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin